Showing 1 - 20 results of 33 for search 'Wee‐Joo Chng', query time: 0.05s
Refine Results
-
1
-
2
Biological Hallmarks and Emerging Strategies to Target STAT3 Signaling in Multiple Myeloma by Jianbiao Zhou, Wee-Joo Chng
Published 2022-03-01
Article -
3
Immunotherapy in Multiple Myeloma by Cinnie Yentia Soekojo, Melissa Ooi, Sanjay de Mel, Wee Joo Chng
Published 2020-03-01
Article -
4
-
5
3-Chloro-3-methyl-2,6-diarylpiperidin-4-ones as Anti-Cancer Agents: Synthesis, Biological Evaluation, Molecular Docking, and In Silico ADMET Prediction by Arulraj Ramalingam, Nurulhuda Mustafa, Wee Joo Chng, Mouna Medimagh, Sivakumar Sambandam, Noureddine Issaoui
Published 2022-08-01
Article -
6
-
7
Counterproductive effects of anti-CD38 and checkpoint inhibitor for the treatment of NK/T cell lymphoma by Wendy W. L. Lee, Jing Quan Lim, Jing Quan Lim, Tiffany P. L. Tang, Daryl Tan, Ser Mei Koh, Kia Joo Puan, Liang Wei Wang, Jackwee Lim, Kim Peng Tan, Wee Joo Chng, Wee Joo Chng, Wee Joo Chng, Soon Thye Lim, Soon Thye Lim, Choon Kiat Ong, Choon Kiat Ong, Olaf Rotzschke, Olaf Rotzschke
Published 2024-04-01
Article -
8
P833: MARCH5 AS A POTENTIAL THERAPEUTIC TARGET IN MULTIPLE MYELOMA by Hamed Bashiri, Ahad Khalilnezhad, Haruhito Totani, Chung Tae-Hoon, Wee Joo Chng, Joe Yeong, Toshio Suda
Published 2023-08-01
Article -
9
Stress granules in cancer: Adaptive dynamics and therapeutic implications by Yunlu Jia, Ruyin Jia, Zhengfeng Dai, Jianbiao Zhou, Jian Ruan, WeeJoo Chng, Zhen Cai, Xiaochen Zhang
Published 2024-08-01
Article -
10
-
11
-
12
-
13
Aberrant non-canonical NF-κB signalling reprograms the epigenome landscape to drive oncogenic transcriptomes in multiple myeloma by Daniel A. Ang, Jean-Michel Carter, Kamalakshi Deka, Joel H. L. Tan, Jianbiao Zhou, Qingfeng Chen, Wee Joo Chng, Nathan Harmston, Yinghui Li
Published 2024-03-01
Article -
14
Impact of ixazomib‐lenalidomide‐dexamethasone therapy on overall survival in multiple myeloma patients: Analysis of the emerging‐markets subgroup of the TOURMALINE‐MM1 trial... by Andrew Spencer, Olga Samoilova, Wee‐Joo Chng, Richard Labotka, Cong Li, Kwang‐Wei Wu, Nakul Saxena, Xu Yan, Jae Hoon Lee, Meral Beksac
Published 2022-11-01
Article -
15
-
16
Proteolysis targeting chimeric molecules as therapy for multiple myeloma: efficacy, biomarker and drug combinations by Su Lin Lim, Alisa Damnernsawad, Pavithra Shyamsunder, Wee Joo Chng, Bing Chen Han, Liang Xu, Jian Pan, Dakle Pushkar Pravin, Serhan Alkan, Jeffrey W. Tyner, H. Phillip Koeffler
Published 2019-06-01
Article -
17
-
18
Super enhancer acquisition drives expression of oncogenic PPP1R15B that regulates protein homeostasis in multiple myeloma by Sinan Xiong, Jianbiao Zhou, Tze King Tan, Tae-Hoon Chung, Tuan Zea Tan, Sabrina Hui-Min Toh, Nicole Xin Ning Tang, Yunlu Jia, Yi Xiang See, Melissa Jane Fullwood, Takaomi Sanda, Wee-Joo Chng
Published 2024-08-01
Article -
19
Efficacy and safety of front-line treatment regimens for Waldenstrom macroglobulinaemia: a systematic review and meta-analysis by Wee-Lee Chan, Vanessa Cui Lian Chong, Ian Jun Yan Wee, Li Mei Poon, Esther Hian Lee Chan, Joanne Lee, Yen-Lin Chee, Anand D. Jeyasekharan, Wee-Joo Chng, Miny Samuel, Sanjay de Mel
Published 2023-09-01
Article -
20
Prior Cancer Is Associated with Lower Atherosclerotic Cardiovascular Disease Risk at First Acute Myocardial Infarction by Chieh Yang Koo, Huili Zheng, Li Ling Tan, Ling-Li Foo, Derek J. Hausenloy, Wee-Joo Chng, Soo Chin Lee, Arthur Mark Richards, Lieng-Hsi Ling, Shir Lynn Lim, Chi-Hang Lee, Mark Y. Chan
Published 2022-10-01
Article